See more : Turkiye Garanti Bankasi A.S. (TKGBY) Income Statement Analysis – Financial Results
Complete financial analysis of Menicon Co., Ltd. (7780.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Menicon Co., Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- AMERISE BIOSCIENCES LIMITED (AMERISE.BO) Income Statement Analysis – Financial Results
- Maxim Power Corp. (MXG.TO) Income Statement Analysis – Financial Results
- Wag! Group Co. (PETWW) Income Statement Analysis – Financial Results
- Sunplus Innovation Technology Inc. (5236.TWO) Income Statement Analysis – Financial Results
- Hexcel Corporation (HXL) Income Statement Analysis – Financial Results
Menicon Co., Ltd. (7780.T)
About Menicon Co., Ltd.
Menicon Co., Ltd. manufactures and sells contact lenses and lens care products. The company offers its products to hospitals, ophthalmology clinics, contact lens stores, eyeglass stores, and drug stores. It exports its products in 80 countries, including the United States, Europe, Oceania, and Asia. Menicon Co., Ltd. was incorporated in 1943 and is headquartered in Nagoya, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 116.19B | 110.19B | 100.17B | 86.21B | 84.52B | 80.90B | 76.67B | 72.05B | 67.33B | 63.13B | 62.21B | 57.93B |
| Cost of Revenue | 55.18B | 51.72B | 47.29B | 40.39B | 39.29B | 38.13B | 35.48B | 33.19B | 30.01B | 28.07B | 26.86B | 24.71B |
| Gross Profit | 61.01B | 58.48B | 52.88B | 45.82B | 45.23B | 42.77B | 41.19B | 38.86B | 37.32B | 35.06B | 35.35B | 33.23B |
| Gross Profit Ratio | 52.51% | 53.07% | 52.79% | 53.15% | 53.51% | 52.87% | 53.73% | 53.93% | 55.43% | 55.53% | 56.83% | 57.35% |
| Research & Development | 5.06B | 4.33B | 3.94B | 3.60B | 3.81B | 3.66B | 3.40B | 3.50B | 3.46B | 2.76B | 2.81B | 2.70B |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 46.93B | 42.10B | 39.00B | 34.13B | 34.35B | 33.45B | 33.33B | 31.40B | 30.46B | 32.19B | 33.06B | 30.68B |
| Other Expenses | 77.00M | 276.00M | 304.00M | 544.00M | -4.00M | 360.00M | 185.00M | 510.20M | 67.77M | 602.60M | 555.44M | 0.00 |
| Operating Expenses | 52.06B | 46.41B | 42.92B | 37.71B | 38.19B | 37.20B | 36.80B | 34.95B | 33.86B | 32.19B | 33.06B | 30.43B |
| Cost & Expenses | 107.24B | 98.13B | 90.22B | 78.10B | 77.49B | 75.33B | 72.28B | 68.14B | 63.87B | 60.27B | 59.91B | 55.14B |
| Interest Income | 82.00M | 36.00M | 19.00M | 4.00M | 4.00M | 7.00M | 10.00M | 14.17M | 30.26M | 50.39M | 55.18M | 0.00 |
| Interest Expense | 672.00M | 361.00M | 332.00M | 229.00M | 188.00M | 174.00M | 200.00M | 240.10M | 262.74M | 313.48M | 296.27M | 283.00M |
| Depreciation & Amortization | 7.95B | 7.45B | 7.29B | 6.03B | 5.42B | 4.64B | 5.01B | 4.65B | 4.36B | 4.20B | 3.77B | -2.55B |
| EBITDA | 15.74B | 19.51B | 17.25B | 14.14B | 12.46B | 10.21B | 9.40B | 9.07B | 8.44B | 7.33B | 6.73B | -53.00M |
| EBITDA Ratio | 13.54% | 17.71% | 17.58% | 16.94% | 14.39% | 12.93% | 12.67% | 12.40% | 11.84% | 11.62% | 10.67% | -0.09% |
| Operating Income | 8.95B | 12.06B | 9.96B | 8.11B | 7.03B | 5.57B | 4.39B | 3.91B | 3.46B | 2.86B | 2.29B | 2.55B |
| Operating Income Ratio | 7.71% | 10.95% | 9.94% | 9.40% | 8.32% | 6.89% | 5.73% | 5.43% | 5.14% | 4.54% | 3.69% | 4.40% |
| Total Other Income/Expenses | -1.84B | -544.00M | -57.00M | 247.00M | -768.00M | 156.00M | -93.00M | 207.99M | 355.56M | -82.29M | 320.12M | -33.76M |
| Income Before Tax | 7.12B | 11.52B | 9.90B | 8.35B | 6.27B | 5.73B | 4.30B | 4.12B | 3.81B | 2.78B | 2.61B | 2.51B |
| Income Before Tax Ratio | 6.12% | 10.45% | 9.88% | 9.69% | 7.41% | 7.08% | 5.61% | 5.72% | 5.66% | 4.41% | 4.20% | 4.34% |
| Income Tax Expense | 2.57B | 4.14B | 3.42B | 2.40B | 2.20B | 2.15B | 1.64B | 1.57B | 1.65B | 1.39B | 1.60B | 1.57B |
| Net Income | 4.54B | 7.38B | 6.48B | 5.95B | 4.06B | 3.58B | 2.66B | 2.54B | 2.22B | 1.43B | 1.01B | 925.00M |
| Net Income Ratio | 3.91% | 6.69% | 6.47% | 6.90% | 4.80% | 4.42% | 3.47% | 3.53% | 3.30% | 2.27% | 1.63% | 1.60% |
| EPS | 59.63 | 97.24 | 85.71 | 39.42 | 56.11 | 47.15 | 37.83 | 35.88 | 31.26 | 21.90 | 15.46 | 14.15 |
| EPS Diluted | 54.86 | 89.77 | 79.06 | 38.61 | 53.46 | 47.15 | 37.42 | 35.46 | 30.80 | 21.90 | 15.46 | 14.15 |
| Weighted Avg Shares Out | 76.10M | 75.86M | 75.61M | 151.00M | 72.36M | 75.84M | 70.23M | 70.89M | 71.16M | 65.38M | 65.38M | 65.38M |
| Weighted Avg Shares Out (Dil) | 82.71M | 82.43M | 82.27M | 154.25M | 76.01M | 75.84M | 71.00M | 71.72M | 72.23M | 65.38M | 65.38M | 65.38M |
Source: https://incomestatements.info
Category: Stock Reports